Skip to Main Content

Autism Biomarker Consortium for Clinical Trials (ABC-CT)

Conditions

Child Development & Autism

What is the purpose of this trial?

Brief Summary:

This is a multicenter longitudinal study that aims to identify, develop and validate a set of measures that can be used as stratification biomarkers and/or sensitive and reliable objective measures of social impairment in autism spectrum disorders (ASD) that could serve as markers of long term clinical outcome. The main study will include 275 individuals: 200 ASD subjects between 6-11 years old, and 75 TD subjects roughly matched by age and sex to the ASD group.

  • Trial with
    National Institute of Mental Health (NIMH)
  • Start Date
    09/20/2016
  • End Date
    11/29/2019
Trial Image

For more information about this study, contact:

Nicole R Wright

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    10/11/2018
  • Study HIC
    #1701018759